Aarti Drugs Share Price Today | Stock Price & Aarti Drugs Share Screener

Track the current stock price of Aarti Drugs with an interactive chart. Analyse AARTIDRUGS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Aarti Drugs stock quote in one place.

The quote of ₹415.00 sits between the 52-week low of ₹319.75 and the 52-week high of ₹520.50, and the latest session moved -1.43% from the previous close.

Screen Aarti Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AARTIDRUGS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE767A01016.

Classification

Identifiers and Leadership

Screen AARTIDRUGS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,815, up from ₹2,575 in 2025.

Latest statistics put total assets at ₹2,815 and shareholder funds at ₹1,549, with a leverage ratio of 0.41.

Screen Aarti Drugs income statement and profit fundamentals. Analyze AARTIDRUGS quarterly results. Aarti Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹721 and net profit was ₹55, equal to earnings per unit of ₹6.05, at an operating margin of 13%.

In that period expenses were ₹625, interest cost ₹8 and tax ₹15. The next period listed, 2026-Jun, shows revenue of ₹704 and net profit of ₹50.

Screen AARTIDRUGS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹254, and net cash flow was an inflow of ₹3.

Over the same period, investing activities used ₹173 and financing activities used ₹77.

See Aarti Drugs shareholding pattern with promoter, FII, and DII holdings. Check Aarti Drugs promoter holding and ownership changes for AARTIDRUGS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 55.03%, foreign institutions 1.58%, domestic institutions 10.22% and the public 23.72%, spread across 144,946 shareholders.

The shareholder count was 144,946 in 2026-Mar, compared with 143,476 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Aarti Drugs. Aarti Drugs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.00 per unit for 2026-March, a yield of 0.48%, compared with ₹1.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.00, ₹1.00 and ₹1.00 per unit.

See which indices include Aarti Drugs stock. Check AARTIDRUGS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Get Aarti Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Aarti Drugs stock events that may affect AARTIDRUGS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 26, 2026, with a record date of September 26, 2026.

It is followed by Quarterly Result Announcement dated July 31, 2026 and Quarterly Result Announcement dated May 15, 2026.

Screen AARTIDRUGS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen AARTIDRUGS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated October 1, 2026 and September 30, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.